The Guardian (USA)

Aspirin and the treatment of cancer

- Letters

A recent review of the medical literature shows that low-dose aspirin taken by patients with cancer (Bitter pill: is aspirin really a wonder drug?, G2, 24 January) is associated with a reduction in cancer deaths, and a reduction in cancer spread (metastases). Over 70 studies have been published, together including 120,000 cancer patients taking aspirin and over 400,000 cancer patients not taking aspirin. A meta-analysis shows a 24% reduction in cancer deaths and a 19% reduction in deaths from all causes in patients taking aspirin. That is: at any time after a diagnosis of cancer, about 19% more patients taking aspirin are alive, compared with patients not taking aspirin.

An author of each report was contacted and asked about bleeding in their patients: 31 replies were received and only one author reported an excess (11%) in the number of patients taking aspirin who had had a bleed, compared with patients not taking aspirin.

A summary of all this evidence is in Public Library of Science, an open medical journal (PLOS: Aspirin in the Treatment of Cancer).

Despite claims on the web and elsewhere of harm, including unsupporte­d claims of deaths due to aspirin, a number of reviews of the published evidence have shown that within each thousand people taking aspirin, only one or two will have a bleed each year, and the bleeds associated with aspirin are less severe than the spontaneou­s stomach bleeds that occur across the community due to a stomach ulcer or infection. Relevant evidence on this is also available at PLOS (Aspirin and fatal bleeding).

While pharmacolo­gists search for more effective anti-cancer agents, informatio­n on low-dose aspirin as an additional treatment of cancer – having a high probabilit­y of benefit and a low chance of harm – should be made widely available to patients, to enable informed discussion­s with their doctors.Professor Peter Elwood,

Ms Janet Pickering and Dr Gareth MorganDivi­sion of population medicine, school of medicine, Cardiff University • J o i n t h e d e b a t e – emailguard­ian.letters@theguardia­n.co m

• Read more Guardian letters – click here to visitgu.com/letters

• Do you have a photo you’d like to share with Guardian readers?Click here to upload itand we’ll publish the best submission­s in the letters spread of our print edition

 ??  ?? ‘Reviews of the published evidence have shown that within each thousand people taking aspirin, only one or two will have a bleed each year,’ say the signatorie­s to this letter. Photograph: Jonathan Brady/PA
‘Reviews of the published evidence have shown that within each thousand people taking aspirin, only one or two will have a bleed each year,’ say the signatorie­s to this letter. Photograph: Jonathan Brady/PA

Newspapers in English

Newspapers from United States